Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

Share Price is delayed by 15 minutes
Get Live Data
260.50    -1.00 (-0.38%)
Bid:
260.00
Ask:
260.50
Spread: 0.50 (0.192%)
Market Cap: £1.04b
AGT Live PriceLast checked at - London Stock Exchange

Intraday AVI Global Trust Share Chart

AVI Urges Wacom To Make Governance Changes

7 May 2025 10:30

RNS Number : 6771H
AVI Global Trust PLC
07 May 2025
Β 

Β 

AVI Urges Wacom To Make Governance Changes

London, 7th May, 2025 - Asset Value Investors Limited ("AVI") launches a campaign on one of AVI Global Trust's ("AGT") portfolio companies, Wacom Corporation (TSE: 6727), hereinafter "Wacom" calling on them to adopt a more market and governance-conscious approach and announces that AVI has submitted shareholder proposals ahead of Wacom's upcoming Annual General Meeting in June. AVI has published a detailed presentation on a dedicated website (www.DrawWacomsFuture.com).

Since AVI started investing on behalf of the funds it manages in Wacom in August 2021, AVI has sought to engage in dialogue with the company, sending letters and presentations with the aim of improving corporate value in a sustainable manner. AVI is deeply concerned by the sluggish performance of the Branded Business segment, which has posted a cumulative loss of more than Y10bn since the fourth quarter of the fiscal year ended 31 March 2022. The company has fallen far short of its mid-term plan targets and significantly underperformed the TOPIX index over this period.

Considering these circumstances, AVI, as the largest shareholder through its holding via AGT and other funds, has decided to initiate a public campaign and submit shareholder proposals at this year's Annual General Meeting with the aim of supporting the sustainable enhancement of corporate value. AVI's shareholder proposals this year include the following resolutions:

Β· Establishment of a Transformation Plan Supervisory Committee

Β· Appointment of one outside director with capital markets background

Β· Amendment to the Articles of Incorporation regarding the handling of acquisition proposals based on the 'Guidelines for Corporate Takeovers' by Ministry of Economy, Trade and Industry

Kazunari Sakai, AVI Japan's Head of Research, stated as follows

"To improve alignment with investor expectations and shareholder interests, Wacom should go beyond the current Board's monitoring role by appointing directors with capital market experience, establishing a supervisory committee, and amending the Articles of Incorporation to align with METI's Guidelines for Corporate Takeovers."

"Although the Branded Business segment continues to face challenges, we are confident that through shortening the product development cycle for entry-level products and strengthening e-commerce channels, Wacom can further reinforce its position as the global leader."

Β 

-Ends-

Β 

About Asset Value Investors (AVI):

AVI is an investment management company established in London, United Kingdom, in 1985. AVI has invested in Japanese equities for nearly 40 years. AVI manages AVI Global Trust ("AGT") and AVI Japan Opportunity Trust ("AJOT") and other funds, collectively investing Y120bn into the Japanese market. AGT and AJOT are public companies whose shares are listed and traded on the main market of the London Stock Exchange.

Β 

Press Enquiries:

Quill PR - AVI@quillpr.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCPKOBKCBKKAPK
Date   Source Headline
22nd Jun 20262:49 pmRNSNet Asset Value(s)
19th Jun 20261:13 pmRNSNet Asset Value(s)
18th Jun 20261:15 pmRNSNet Asset Value(s)
17th Jun 20261:51 pmRNSNet Asset Value(s)
16th Jun 20265:06 pmRNSTransaction in Own Shares
16th Jun 20262:04 pmRNSNet Asset Value(s)
15th Jun 20265:11 pmRNSTransaction in Own Shares
15th Jun 20261:16 pmRNSNet Asset Value(s)
12th Jun 202612:01 pmRNSNet Asset Value(s)
11th Jun 20262:41 pmRNSNet Asset Value(s)
10th Jun 20262:13 pmRNSNet Asset Value(s)
9th Jun 20265:10 pmRNSTransaction in Own Shares
9th Jun 20262:01 pmRNSNet Asset Value(s)
8th Jun 20264:20 pmRNSMonthly Factsheet
8th Jun 20261:48 pmRNSNet Asset Value(s)
5th Jun 20265:13 pmRNSTransaction in Own Shares
5th Jun 202612:41 pmRNSNet Asset Value(s)
4th Jun 20261:04 pmRNSNet Asset Value(s)
4th Jun 20267:00 amRNSHalf-year Financial Report
3rd Jun 20261:50 pmRNSNet Asset Value(s)
2nd Jun 20261:23 pmRNSNet Asset Value(s)
1st Jun 20265:17 pmRNSTransaction in Own Shares
1st Jun 20262:58 pmRNSNet Asset Value(s)
1st Jun 202610:22 amRNSTotal Voting Rights
29th May 202611:31 amRNSNet Asset Value(s)
28th May 20261:55 pmRNSNet Asset Value(s)
27th May 20265:05 pmRNSTransaction in Own Shares
27th May 20262:54 pmRNSNet Asset Value(s)
26th May 20265:41 pmRNSTransaction in Own Shares
26th May 20261:15 pmRNSNet Asset Value(s)
22nd May 20265:12 pmRNSTransaction in Own Shares
22nd May 20261:20 pmRNSNet Asset Value(s)
21st May 20265:11 pmRNSTransaction in Own Shares
21st May 202611:56 amRNSNet Asset Value(s)
20th May 20261:55 pmRNSNet Asset Value(s)
19th May 20265:17 pmRNSTransaction in Own Shares
19th May 202611:43 amRNSNet Asset Value(s)
18th May 20261:06 pmRNSNet Asset Value(s)
15th May 202612:20 pmRNSNet Asset Value(s)
14th May 20262:21 pmRNSMonthly Factsheet
14th May 20261:03 pmRNSNet Asset Value(s)
13th May 202612:51 pmRNSNet Asset Value(s)
12th May 20261:38 pmRNSNet Asset Value(s)
11th May 20265:30 pmRNSTransaction in Own Shares
11th May 20261:37 pmRNSNet Asset Value(s)
8th May 20261:43 pmRNSNet Asset Value(s)
7th May 20265:30 pmRNSTransaction in Own Shares
7th May 202612:42 pmRNSNet Asset Value(s)
6th May 20265:23 pmRNSTransaction in Own Shares
6th May 202612:32 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.